Tackling antibiotic resistanceKaren Bush, Helen I. Zgurskaya, Pamela J. Yeh et al.|Nature Reviews Microbiology|2011Cited by 1.1k
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millenniumNarcisa Mesaros, Françoise Van Bambeke, Patrice Nordmann et al.|Clinical Microbiology and Infection|2007Cited by 575
Tissue concentrations: do we ever learn?Johan W. Mouton, Otto Cars, Ursula Theuretzbacher et al.|Journal of Antimicrobial Chemotherapy|2007Cited by 337
Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?Isabelle Delattre, Paul M. Tulkens, Fabio Taccone et al.|Expert Review of Anti-infective Therapy|2017Cited by 103
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administrationPierre-François Laterre, Thierry Dugernier, Xavier Wittebole et al.|Journal of Antimicrobial Chemotherapy|2014Cited by 87